FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079406923> ?p ?o ?g. }

• W2079406923 endingPage "1312" @default.
• W2079406923 startingPage "1302" @default.
• W2079406923 abstract "To determine the hemodynamic effects of i.v. milrinone lactate in pediatric patients with nonhyperdynamic septic shock. Specifically we tested the hypothesis that i.v. milrinone would increase cardiac index by 20% and decrease systemic vascular resistance index by 20% during a 2-h study period.Prospective, double-blinded, randomized, placebo-controlled, descriptive, interventional study.Twenty-six-bed pediatric ICU at Children's Medical Center of Dallas and a 10-bed pediatric trauma ICU at Parkland Memorial Hospital.Twelve patients (age range, 9 months to 15 years) with nonhyperdynamic septic shock despite administration of catecholamines (cardiac index [CI] normal [3.5 to 5.5 L/min/m2] or low [< or =3.5 L/min/m2]; systemic vascular resistance index [SVRI] normal [800 to 1,600 dyne.s.cm5/m2] or high [> or =1,600 dyne.s.cm5/m2]; and pulmonary capillary wedge pressure [PCWP] normal [8 to 12 mm Hg] or higher) with clinical signs of poor perfusion were enrolled, randomized, and treated in a blinded fashion with i.v. milrinone and placebo.Patients were randomized into two groups. Group A received a loading dose of 50 micrograms/kg i.v. of milrinone followed by a continuous i.v. infusion of 0.5 microgram/kg/min while group B received an equal volume loading dose and continuous infusion of placebo. After 2 h, group A received an equal-volume loading dose followed by a continuous infusion of placebo while the milrinone infusion continued, while group B received a 50 micrograms/kg loading dose of milrinone followed by a continuous infusion of 0.5 microgram/kg/min while the placebo infusion remained. Outcome variable were measured at baseline, 0.5, 1.0, 2.0, 2.5, 3.0, and 4.0 h. Echocardiographic measurements were taken at baseline, hour 2, and hour 4 in all subjects. No changes in other inotropic or mechanical ventilatory support were allowed during the study period.Milrinone significantly increased CI, stroke volume index (SVI), right and left ventricular stroke work index, and oxygen delivery (Do2) at 0.5, 1.0, and 2.0 h postloading dose (p < 0.05) while significantly decreasing SVRI, pulmonary vascular resistance index, and mean pulmonary arterial pressure at 0.5, 1.0, and 2.0 h postloading dose (p < 0.05). No clinically or statistically significant changes in heart rate, systolic and diastolic BP, mean systemic arterial pressure, or PCWP were observed during milrinone treatment compared to placebo.CI, SVI, and Do2 significantly increased while SVRI significantly decreased when compared to placebo after i.v. administration of milrinone to pediatric patients with nonhyperdynamic septic shock. No adverse effects were observed. In a volume-resuscitated pediatric patient with septic shock, when administered in addition to catecholamines, milrinone will improve cardiovascular function." @default.
• W2079406923 created "2016-06-24" @default.
• W2079406923 creator A5011150335 @default.
• W2079406923 creator A5017135863 @default.
• W2079406923 creator A5017285508 @default.
• W2079406923 creator A5031162964 @default.
• W2079406923 creator A5046552149 @default.
• W2079406923 creator A5052194897 @default.
• W2079406923 creator A5056587248 @default.
• W2079406923 creator A5072401407 @default.
• W2079406923 date "1996-05-01" @default.
• W2079406923 modified "2023-10-05" @default.
• W2079406923 title "Hemodynamic Effects of IV Milrinone Lactate in Pediatric Patients With Septic Shock" @default.
• W2079406923 cites W1963862704 @default.
• W2079406923 cites W1967354447 @default.
• W2079406923 cites W1972945075 @default.
• W2079406923 cites W1982947678 @default.
• W2079406923 cites W1988380227 @default.
• W2079406923 cites W1994818796 @default.
• W2079406923 cites W2005357317 @default.
• W2079406923 cites W2006887827 @default.
• W2079406923 cites W2006919847 @default.
• W2079406923 cites W2008145970 @default.
• W2079406923 cites W2010633664 @default.
• W2079406923 cites W2020413957 @default.
• W2079406923 cites W2022331655 @default.
• W2079406923 cites W2025570168 @default.
• W2079406923 cites W2027049770 @default.
• W2079406923 cites W2029808802 @default.
• W2079406923 cites W2030155811 @default.
• W2079406923 cites W2036909269 @default.
• W2079406923 cites W2043570710 @default.
• W2079406923 cites W2043662454 @default.
• W2079406923 cites W2045010042 @default.
• W2079406923 cites W2050034675 @default.
• W2079406923 cites W2050881721 @default.
• W2079406923 cites W2053060395 @default.
• W2079406923 cites W2054896949 @default.
• W2079406923 cites W2056094016 @default.
• W2079406923 cites W2056761641 @default.
• W2079406923 cites W2056853181 @default.
• W2079406923 cites W2066321520 @default.
• W2079406923 cites W2068752964 @default.
• W2079406923 cites W2075035529 @default.
• W2079406923 cites W2075584178 @default.
• W2079406923 cites W2084283682 @default.
• W2079406923 cites W2086870390 @default.
• W2079406923 cites W2087246147 @default.
• W2079406923 cites W2093697327 @default.
• W2079406923 cites W2107212779 @default.
• W2079406923 cites W2125642970 @default.
• W2079406923 cites W2140128769 @default.
• W2079406923 cites W2143732220 @default.
• W2079406923 cites W2599527603 @default.
• W2079406923 cites W4302342217 @default.
• W2079406923 doi "https://doi.org/10.1378/chest.109.5.1302" @default.
• W2079406923 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8625683" @default.
• W2079406923 hasPublicationYear "1996" @default.
• W2079406923 type Work @default.
• W2079406923 sameAs 2079406923 @default.
• W2079406923 citedByCount "183" @default.
• W2079406923 countsByYear W20794069232012 @default.
• W2079406923 countsByYear W20794069232013 @default.
• W2079406923 countsByYear W20794069232014 @default.
• W2079406923 countsByYear W20794069232015 @default.
• W2079406923 countsByYear W20794069232016 @default.
• W2079406923 countsByYear W20794069232017 @default.
• W2079406923 countsByYear W20794069232018 @default.
• W2079406923 countsByYear W20794069232019 @default.
• W2079406923 countsByYear W20794069232020 @default.
• W2079406923 countsByYear W20794069232021 @default.
• W2079406923 countsByYear W20794069232022 @default.
• W2079406923 crossrefType "journal-article" @default.
• W2079406923 hasAuthorship W2079406923A5011150335 @default.
• W2079406923 hasAuthorship W2079406923A5017135863 @default.
• W2079406923 hasAuthorship W2079406923A5017285508 @default.
• W2079406923 hasAuthorship W2079406923A5031162964 @default.
• W2079406923 hasAuthorship W2079406923A5046552149 @default.
• W2079406923 hasAuthorship W2079406923A5052194897 @default.
• W2079406923 hasAuthorship W2079406923A5056587248 @default.
• W2079406923 hasAuthorship W2079406923A5072401407 @default.
• W2079406923 hasConcept C139940330 @default.
• W2079406923 hasConcept C141071460 @default.
• W2079406923 hasConcept C146556889 @default.
• W2079406923 hasConcept C164705383 @default.
• W2079406923 hasConcept C178853913 @default.
• W2079406923 hasConcept C2776645727 @default.
• W2079406923 hasConcept C2777628635 @default.
• W2079406923 hasConcept C2778384902 @default.
• W2079406923 hasConcept C31861589 @default.
• W2079406923 hasConcept C35294091 @default.
• W2079406923 hasConcept C42219234 @default.
• W2079406923 hasConcept C58245268 @default.
• W2079406923 hasConcept C71924100 @default.
• W2079406923 hasConceptScore W2079406923C139940330 @default.
• W2079406923 hasConceptScore W2079406923C141071460 @default.
• W2079406923 hasConceptScore W2079406923C146556889 @default.
• W2079406923 hasConceptScore W2079406923C164705383 @default.

• next